Brochures Overview
WuXi AppTec DMPK provides end-to-end radiolabeling drug development services, including [14C] and [3H] radiolabeling synthesis, comprehensive preclinical ADME studies in rodents and large animals covering mass balance, quantitative whole body autoradiography (QWBA), and metabolite profiling/identification, as well as clinical AME studies.
Complete the form to view and download this brochure.
Stay Connected
Keep up with the latest news and insights.